At 7.7% CAGR, Middle East & Africa Traumatic Brain Injury Diagnostics Equipment Market Projected to be Worth US$ 149.57 Million by 2030, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa traumatic brain injury diagnostics equipment market was valued at US$ 82.73 million in 2022 and is expected to reach US$ 149.57 million by 2030, registering a CAGR of 7.7% from 2022 to 2030. Accelerated demand for advanced diagnostic equipment and growing use of MRI over CT to limit inpatient mortality and marginally reduce diagnostic cost are among the critical factors attributed to drive the Middle East & Africa traumatic brain injury diagnostics equipment market growth.

According to the Medical Research Council 2022 report, 10 million people across the world sustain traumatic brain injury (TBI) annually. Among these, the male population was 1.5 times higher than females admitted to hospitals for a head injury. As per The Economist Intelligence Unit report, the global healthcare burden of TBI is estimated to be around US$ 400 billion annually. The most common form of ABI is TBI due to an accident or stroke. In October 2023, bioMérieux announced Conformité Européenne (CE) marking for "VIDAS TBI (GFAP, UCH-L1)," a test intended to improve the assessment of patients suffering from mild traumatic brain injury (mTBI). VIDAS TBI (GFAP, UCH-L1) test measures the concentration of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1)—the two brain biomarkers released into the bloodstream starting from the first hour following a brain injury. It is an easy-to-interpret test providing a test window of up to 12 hours after injury, which can help in shortening total emergency department workup time. The product's commercial launch was in 2023 for selected North African markets; the global launch is planned in 2024 or 2025.

On the contrary, adverse effects of contrast medium/agent hamper the growth of Middle East & Africa traumatic brain injury diagnostics equipment market.

Based on techniques, the Middle East & Africa traumatic brain injury diagnostics equipment market is segmented into non-invasive, invasive, and combination techniques. The non-invasive segment held 49.9% market share in 2022, amassing US$ 41.26 million. It is projected to garner US$ 77.47 million by 2030 to register 8.2% CAGR during 2022–2030. Furthermore, the non-invasive segment is subcategorized into electroencephalography (EEG), brain–computer interface (BCI), eye tracking and near-infrared spectroscopy (NIRS), magnetic resonance imaging (MRI), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), cerebral metabolic rate of oxygen (CMRO2), intracranial pressure, and others .Additionally, invasive segment is subsegmented into cerebral perfusion pressure (CPP) and pressure reactivity index (PRx), partial brain tissue oxygen pressure (PbtO2), cerebral microdialysis (CMD), intracranial pressure, and others.

In terms of device, the Middle East & Africa traumatic brain injury diagnostics equipment market is bifurcated into imaging devices and monitoring devices. The imaging devices segment held 79.3% share of Middle East & Africa traumatic brain injury diagnostics equipment market in 2022, amassing US$ 65.63 million. It is anticipated to garner US$ 116.37 million by 2030 to expand at 7.4% CAGR during 2022–2030.

By end user, the Middle East & Africa traumatic brain injury diagnostics equipment market is divided into hospitals and clinics, diagnostic centers, and others. The hospitals and clinics segment held 53.3% share of Middle East & Africa traumatic brain injury diagnostics equipment market in 2022, amassing US$ 44.06 million. It is projected to garner US$ 78.60 million by 2030 to expand at 7.5% CAGR from 2022 to 2030.

Based on country, the Middle East & Africa traumatic brain injury diagnostics equipment market is categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 34.9% share of Middle East & Africa traumatic brain injury diagnostics equipment market in 2022. It was assessed at US$ 28.88 million in 2022 and is likely to hit US$ 51.02 million by 2030, registering a CAGR of 7.4% during 2022–2030.

Key players operating in the Middle East & Africa traumatic brain injury diagnostics equipment market are GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Raumedic AG, Soterix Medical Inc, Medtronic Plc, and Compumedics Ltd, among others.

• In April 2022, NeuraSignal Inc announced the upgradation of its NovaSignal Platform. A new feature called Morphology has been added to the platform, providing advanced analysis of cerebral waveforms. The new feature enabled faster and easier assessment of patients with suspected neurological conditions such as stroke.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com